Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial Officer

Dr. Ruffner is a US-trained hematologist/oncologist with over 25 years of clinical care, oncology biotechnology and pharmaceutical drug development experience Mr. Levine has over 20 years of corporate and investment banking experience in the biotechnolo... Biopharmaceuticals, Oncology, Personnel Cardiff Oncology, Onvansertib, Colorectal Cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news